Published in:
01-09-2019 | Case Report
Metachronous Hepatic Angiosarcoma Presenting as a Mimic of Recurrent Hepatocellular Carcinoma
Authors:
Eric K. C. Lau, Bernette Tsai, Harry Morrison, Michael Deftos, Albert Y. Lin
Published in:
Journal of Gastrointestinal Cancer
|
Issue 3/2019
Login to get access
Excerpt
Primary hepatic angiosarcoma (PHA) is the third most common primary liver malignancy, after hepatocellular carcinoma and cholangiocarcinoma, accounting for 2% of primary liver malignancies and less than 1% of all sarcomas [
1,
2]. PHA has been known to present in men over 60 years of age and has been associated with neurofibromatosis-1, anabolic steroids, hemochromatosis, vinyl chloride, thorotrast radiocontrast, and arsenic, although most cases are idiopathic [
2,
3]. PHA is a very aggressive malignancy with a historical median survival of only 5 months despite treatment [
4]. Our case highlights how this deadly disease can present as a mimic of recurrent hepatocellular carcinoma (HCC) in a patient with known prior HCC. …
